Citation:Spelman L, Rosen R, Knudsen KM, Zibert JR, Freeman M 2018
From Cancer Guidelines Wiki
Citation
Spelman L, Rosen R, Knudsen KM, Zibert JR, Freeman M. Ingenol mebutate 0.05% gel under occlusion is efficacious in treating superficial basal cell carcinoma. B J Dermatol. 2014;171(Suppl. 4):58–9.
Critical appraisals
Compare quality appraisals for each clinical question
- [[Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?</span></span></span>»]] (compare critical appraisals)
- [[Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?|Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What role does Ingenol mebutate gel have in the treatment and management of basal cell and/or squamous cell carcinomas?</span></span></span></span>»]] (compare critical appraisals)